NYKODE THERAPEUTICS ASA: årsregnskap 2016 vs 2015
Grew 60% on revenue, fresh owner capital
approved 2017-04-04; registry 2017-06-07; journal 2017 398189
Summary
What changed
Comparing Årsregnskap 2016 with 2015 for NYKODE THERAPEUTICS ASA. Revenue 5.62m NOK → 9.00m NOK (+60.0%). Equity 17.63m NOK → 234.40m NOK.
On the constructive side: revenue rose; equity strengthened; cash rose.
Net constructive year on the published lines.
At a glance
Scorecard
Revenue
5.62m NOK
9.00m NOK
+60.0%
Equity
17.63m NOK
234.40m NOK
+1229.8%
Cash
6.88m NOK
19.63m NOK
+185.3%
Total assets
21.42m NOK
252.01m NOK
+1076.4%
What improved
-
↑
Revenue rose
Operating income / revenue moved from 5.62m NOK to 9.00m NOK (+60.0% YoY). Calculated
-
↑
Equity strengthened
Book equity 17.63m NOK → 234.40m NOK (equity ratio 82.3% → 93.0%). Calculated
-
↑
Cash rose
Bank deposits 6.88m NOK → 19.63m NOK (+185.3% YoY). Calculated
-
↑
Owners injected capital
Paid-in equity rose 56.37m NOK → 289.36m NOK (+233.00m NOK). Reported fact